MISSLING CHRISTOPHER U 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Jan 12, 2024
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02−125,000→ 125,000 totalExercise: $10.09From: 2024-01-02Exp: 2032-06-27→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]On June 27, 2022, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which included topline data readout of ANAVEX2-73-RS-003 EXCELLENCE clinical trial in Rett Syndrome. The performance criteria for this milestone was met, resulting in vesting of the option as to 125,000 shares.